Ozempic maker struggles as it loses ground to rivals in weight-loss market
Novo Nordisk cuts sales and profit forecasts as it continues to lose ground to Mounjaro firm Eli Lilly The maker of Ozempic and Wegovy has cut its sales and profit forecasts as it continues to fall behind in the competitive market for obesity and diabetes treatments. Novo Nordisk’s chief (…)
Site référencé:
The Guardian (Asia Pacific)
2847.jpg?width=140&quality=85&auto=format&fit=max&s=6294b6e1775d2a17950bf012b978e85a, 2847.jpg?width=460&quality=85&auto=format&fit=max&s=8d07e42f8ba690d3879851340f11f6eb, 2847.jpg?width=700&quality=85&auto=format&fit=max&s=0e2d0a82e6ad2e53e2b962b0aa290d0a
The Guardian (Asia Pacific)
In his first term, Donald Trump called journalists the enemy. This time around, he’s treating us like one | Betsy Reed
5/11/2025
Colossal Wreck review – sharp-eyed dispatch from the Kubrickian weirdness of Dubai during Cop28
5/11/2025
The Spin | Times are bleak for Pakistan cricket but Test game offers hope of salvation
5/11/2025
Destiny Udogie revealed as footballer allegedly threatened at gunpoint by an agent
5/11/2025
Drink tea, tidy up and take action ! Can advice from artists really improve your life ?
5/11/2025
‘Baz Bawl’ : Australian media stoke Ashes rivalry with welcome for England’s Stokes
5/11/2025